Huang, J., Li, L., Xu, L., Feng, L., Wang, Y., SIK, A. G., . . . Li, X. Methyl 3-Bromo-4,5-dihydroxybenzoate Attenuates Inflammatory Bowel Disease by Regulating TLR/NF-κB Pathways. MDPI AG.
Chicago Style (17th ed.) CitationHuang, Jing, et al. Methyl 3-Bromo-4,5-dihydroxybenzoate Attenuates Inflammatory Bowel Disease by Regulating TLR/NF-κB Pathways. MDPI AG.
MLA (9th ed.) CitationHuang, Jing, et al. Methyl 3-Bromo-4,5-dihydroxybenzoate Attenuates Inflammatory Bowel Disease by Regulating TLR/NF-κB Pathways. MDPI AG.
Warning: These citations may not always be 100% accurate.